Literature DB >> 17258562

Management of pleural space infections: a population-based analysis.

Farhood Farjah1, Rebecca Gaston Symons, Bahirathan Krishnadasan, Douglas E Wood, David R Flum.   

Abstract

OBJECTIVE: Management options for pleural space infections have changed over the last 2 decades. This study evaluated trends over time in the incidence of disease and use of different management strategies and their associated outcomes.
METHODS: A retrospective study was performed by using a statewide administrative database of all hospitalizations for pleural space infections between 1987 and 2004.
RESULTS: Four thousand four hundred twenty-four patients (age, 57.1 +/- 18.6 years; 67% male; comorbidity index, 1.1 +/- 1.9) were hospitalized with pleural space infections. The incidence rate increased 2.8% per year (95% confidence interval, 2.2%-3.4%; P < .001). Overall, 51.6% of patients underwent an operation, and the proportion increased from 42.4% in 1987 to 58.4% in 2004 (P < .001). The risk of death within 30 days was less for patients undergoing operations compared with that for patients not undergoing operations (5.4% vs 16.6%, P < .001); however, patients undergoing operations were younger (52.9 +/- 17.6 years vs 61.5 +/- 18.6 years, P < .001) and had a lower comorbidity index (0.8 +/- 1.6 vs 1.4 +/- 2.1, P < .001). After adjusting for age, sex, comorbidity index, and insurance status, patients undergoing operative therapy had a 58% lower risk of death (odds ratio, 0.42; 95% confidence interval, 0.32-0.56; P < .001) than those undergoing nonoperative management.
CONCLUSIONS: The incidence of pleural space infections and the proportion of patients undergoing operative management have increased over time. Patients undergoing operations were younger and had less comorbid illness than those not undergoing operations but had a much lower risk of early death, even after adjusting for these factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17258562     DOI: 10.1016/j.jtcvs.2006.09.038

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  36 in total

Review 1.  Pleural infection.

Authors:  John M Wrightson; Nick A Maskell
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

2.  Application of Thoracoscopic Hybrid Surgery in the Treatment of Stage III Tuberculous Empyema.

Authors:  Zhao Liu; Sizhe Cao; Changsheng Zhu; Lin Wei; Huijun Zhang; Qian Li
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-08-14       Impact factor: 1.520

Review 3.  Post-resection complications: abscesses, empyemas, bronchopleural fistulas.

Authors:  Matthew Egyud; Kei Suzuki
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

4.  Rebuttal from Drs Colice and Idell.

Authors:  Gene L Colice; Steven Idell
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

Review 5.  Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.

Authors:  Francesco Piccolo; Natalia Popowicz; Donny Wong; Yun Chor Gary Lee
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

6.  Therapeutic strategy for acute pleural empyema: comparison between retrospective study and prospective study.

Authors:  Hitoshi Suzuki; Shin Shomura; Yasuhiro Sawada; Akira Shimamoto; Chiaki Kondo; Motoshi Takao; Hideto Shimpo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-05-03

7.  The ongoing struggle with empyema management: is surgery really the answer?

Authors:  Eihab O Bedawi; Lonny Yarmus; Najib M Rahman
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

Review 8.  Fibrin turnover and pleural organization: bench to bedside.

Authors:  Andrey A Komissarov; Najib Rahman; Y C Gary Lee; Galina Florova; Sreerama Shetty; Richard Idell; Mitsuo Ikebe; Kumuda Das; Torry A Tucker; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

Review 9.  Stage-directed therapy of pleural empyema.

Authors:  Martin Reichert; Matthias Hecker; Biruta Witte; Johannes Bodner; Winfried Padberg; Markus A Weigand; Andreas Hecker
Journal:  Langenbecks Arch Surg       Date:  2016-11-04       Impact factor: 3.445

Review 10.  Pneumonia and empyema: causal, casual or unknown.

Authors:  Lindsay McCauley; Nathan Dean
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.